Company: BLNE
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001641172-25-004793
Chunk: 68

Company: Beeline Holdings, Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1
Chunk 68
---
 you we will enter into a definitive agreement or receive any proceeds
from the at-the-market offering. If obtaining sufficient funding from these offerings were to prove unavailable or prohibitively dilutive,
we will need to secure another source of funding in order to satisfy our working capital needs. Even if we sell the maximum amount of
$10 million of shares of Common Stock under the ELOC Agreement, we may still need additional capital to fully implement our business,
operating and development plans. Should the financing we require to sustain our working capital needs be unavailable or prohibitively
expensive when we require it or expose us to substantial restrictive covenants or limitations, the consequences could be a material adverse
effect on our business, operating results, financial condition and prospects.

Further, certain of our outstanding
derivatives securities, including convertible preferred stock and warrants, contain anti-dilution price protection provisions which provide
for adjustments to conversion and exercise prices, and an increase in the shares underlying such securities, if we sell shares at a per
share price below the applicable conversion or exercise price. Therefore, to the extent we issue shares at prices that are lower than
these conversion and exercise prices and we do not obtain waivers of these provisions, these conversion and exercise prices will be lowered
to the new lower sale price, and the shares of common stock underlying such securities will increase accordingly. This would cause additional
dilution to our common stockholders and result in our receiving less cash upon exercise of warrants.

By virtue of the terms of the ELOC
Agreement or any At-The-Market Offering Agreement if and when we enter into such an agreement, it is not possible to predict the number
of shares we will sell nor the prices at which we will sell the shares in such transactions, the amount of proceeds we will raise and
the timing thereof including whether they will be sufficient for our working capital needs and business plans (including the timely payment
of our debt obligations), nor the consequences (including dilution to existing shareholders) which may result therefrom.

An active trading market for
our common stock may not develop.

With limited exceptions, the volume
of sales of our common stock has not been high. Although our common stock trades on Nasdaq, an active trading market for our shares may
never develop or be sustained. If an active market for our common stock does not develop, it may be difficult to sell our common stock
without depressing the market price for the common stock, or at all.

We are incurring significant
additional costs